Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study
Abstract BackgroundHigh-intensity chemotherapy for non-Hodgkin lymphoma (NHL) has been shown to improve survival outcomes. However, its substantial toxicity may induce or exacerbate patient frailty, which is strongly associated with treatment interruptions, increased adverse e...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
JMIR Publications
2025-10-01
|
| Col·lecció: | JMIR Research Protocols |
| Accés en línia: | https://www.researchprotocols.org/2025/1/e76628 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|